Literature DB >> 30097727

Escherichia coli-derived BMP-2-absorbed β-TCP granules induce bone regeneration in rabbit critical-sized femoral segmental defects.

Yu Kuroiwa1, Takahiro Niikura2, Sang Yang Lee1, Keisuke Oe1, Takashi Iwakura1, Tomoaki Fukui1, Tomoyuki Matsumoto1, Takehiko Matsushita1, Kotaro Nishida1, Ryosuke Kuroda1.   

Abstract

PURPOSE: This study investigated whether Escherichia coli-derived bone morphogenetic protein (BMP)-2 (E-BMP-2) adsorbed onto β-tricalcium phosphate (β-TCP) granules can induce bone regeneration in critical-size femoral segmental defects in rabbits.
METHODS: Bone defects 20 mm in size and stabilized with an external fixator were created in the femur of New Zealand white rabbits, which were divided into BMP-2 and control groups. E-BMP-2-loaded β-TCP granules were implanted into defects of the BMP-2 group, whereas defects in the controls were implanted with β-TCP granules alone. At 12 and 24 weeks after surgery, radiographs were obtained of the femurs and histological and biomechanical assessments of the defect area were performed. Bone regeneration was quantified using micro-computed tomography at 24 weeks.
RESULTS: Radiographic and histologic analyses revealed bone regeneration in the BMP-2 group but not the control group; no fracturing of newly formed bone occurred when the external fixator was removed at 12 weeks. At 24 weeks, tissue mineral density, the ratio of bone volume to total volume, and volumetric bone mineral density of the callus were higher in the BMP-2 group than in control animals. In the former, ultimate stress, extrinsic stiffness, and failure energy measurements for the femurs were higher at 24 weeks than at 12 weeks.
CONCLUSION: E-BMP-2-loaded β-TCP granules can effectively promote bone regeneration in long bone defects.

Entities:  

Keywords:  Bone defect; Bone morphogenetic protein-2; Bone regeneration; β-Tricalcium phosphate

Mesh:

Substances:

Year:  2018        PMID: 30097727     DOI: 10.1007/s00264-018-4079-4

Source DB:  PubMed          Journal:  Int Orthop        ISSN: 0341-2695            Impact factor:   3.075


  22 in total

1.  Collagen-chondroitin sulfate-based PLLA-SAIB-coated rhBMP-2 delivery system for bone repair.

Authors:  Dilek Sendil Keskin; Aysen Tezcaner; Petek Korkusuz; Feza Korkusuz; Vasif Hasirci
Journal:  Biomaterials       Date:  2005-06       Impact factor: 12.479

2.  Bone: formation by autoinduction.

Authors:  M R Urist
Journal:  Science       Date:  1965-11-12       Impact factor: 47.728

3.  Efficacy of interspinous process lumbar fusion with recombinant human bone morphogenetic protein-2 delivered with a synthetic polymer and β-tricalcium phosphate in a rabbit model.

Authors:  Tomiya Matsumoto; Hiromitsu Toyoda; Sho Dohzono; Hiroyuki Yasuda; Shigeyuki Wakitani; Hiroaki Nakamura; Kunio Takaoka
Journal:  Eur Spine J       Date:  2011-12-28       Impact factor: 3.134

4.  Bone regeneration in standardized bone defects with autografts or bone substitutes in combination with platelet concentrate: a histologic and histomorphometric study in the mandibles of minipigs.

Authors:  Simon Storgård Jensen; Nina Broggini; Gernot Weibrich; Erik Hjôrting-Hansen; Robert Schenk; Daniel Buser
Journal:  Int J Oral Maxillofac Implants       Date:  2005 Sep-Oct       Impact factor: 2.804

5.  The effect of a fibrin-fibronectin/beta-tricalcium phosphate/recombinant human bone morphogenetic protein-2 system on bone formation in rat calvarial defects.

Authors:  Sung-Jae Hong; Chang-Sung Kim; Dong-Kwan Han; Ik-Hyun Cho; Ui-Won Jung; Seong-Ho Choi; Chong-Kwan Kim; Kyoo-Sung Cho
Journal:  Biomaterials       Date:  2006-03-29       Impact factor: 12.479

6.  Effect of Escherichia coli-produced recombinant human bone morphogenetic protein 2 on the regeneration of canine segmental ulnar defects.

Authors:  Yasuji Harada; Takamasa Itoi; Shigeyuki Wakitani; Hiroyuki Irie; Michiko Sakamoto; Dongwei Zhao; Yoshinori Nezu; Takuya Yogo; Yasushi Hara; Masahiro Tagawa
Journal:  J Bone Miner Metab       Date:  2011-11-02       Impact factor: 2.626

7.  Histology of human alveolar bone regeneration with a porous tricalcium phosphate. A report of two cases.

Authors:  I R Zerbo; A L Bronckers; G L de Lange; G J van Beek; E H Burger
Journal:  Clin Oral Implants Res       Date:  2001-08       Impact factor: 5.977

8.  High doses of bone morphogenetic protein 2 induce structurally abnormal bone and inflammation in vivo.

Authors:  Janette N Zara; Ronald K Siu; Xinli Zhang; Jia Shen; Richard Ngo; Min Lee; Weiming Li; Michael Chiang; Jonguk Chung; Jinny Kwak; Benjamin M Wu; Kang Ting; Chia Soo
Journal:  Tissue Eng Part A       Date:  2011-03-03       Impact factor: 3.845

9.  Application of rhBMP-7 and platelet-rich plasma in the treatment of long bone non-unions: a prospective randomised clinical study on 120 patients.

Authors:  G M Calori; L Tagliabue; L Gala; M d'Imporzano; G Peretti; W Albisetti
Journal:  Injury       Date:  2008-11-22       Impact factor: 2.586

10.  Recombinant human bone morphogenetic protein-2 in debridement and impacted bone graft for the treatment of femoral head osteonecrosis.

Authors:  Wei Sun; Zirong Li; Fuqiang Gao; Zhencai Shi; Qidong Zhang; Wanshou Guo
Journal:  PLoS One       Date:  2014-06-23       Impact factor: 3.240

View more
  5 in total

1.  Is ceramics an appropriate bone morphogenetic protein delivery system for clinical use?

Authors:  Slobodan Vukicevic; Nikola Stokovic; Marko Pecina
Journal:  Int Orthop       Date:  2019-03-15       Impact factor: 3.075

2.  Comparison of synthetic ceramic products formulated with autologous blood coagulum containing rhBMP6 for induction of bone formation.

Authors:  Nikola Stokovic; Natalia Ivanjko; Viktorija Rumenovic; Anita Breski; Kuber T Sampath; Mihaela Peric; Marko Pecina; Slobodan Vukicevic
Journal:  Int Orthop       Date:  2022-08-22       Impact factor: 3.479

3.  A novel autologous bone graft substitute containing rhBMP6 in autologous blood coagulum with synthetic ceramics for reconstruction of a large humerus segmental gunshot defect in a dog: The first veterinary patient to receive a novel osteoinductive therapy.

Authors:  Marko Pecin; Nikola Stokovic; Natalia Ivanjko; Ana Smajlovic; Mario Kreszinger; Hrvoje Capak; Zoran Vrbanac; Hermann Oppermann; Drazen Maticic; Slobodan Vukicevic
Journal:  Bone Rep       Date:  2021-02-25

4.  Functionalized 3D-printed silk-hydroxyapatite scaffolds for enhanced bone regeneration with innervation and vascularization.

Authors:  Vincent Fitzpatrick; Zaira Martín-Moldes; Anna Deck; Ruben Torres-Sanchez; Anne Valat; Dana Cairns; Chunmei Li; David L Kaplan
Journal:  Biomaterials       Date:  2021-07-01       Impact factor: 15.304

5.  Enhanced osseointegration of three-dimensional supramolecular bioactive interface through osteoporotic microenvironment regulation.

Authors:  Haotian Bai; Yue Zhao; Chenyu Wang; Zhonghan Wang; Jincheng Wang; Hou Liu; Yubin Feng; Quan Lin; Zuhao Li; He Liu
Journal:  Theranostics       Date:  2020-03-26       Impact factor: 11.556

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.